A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)

Mise à jour : Il y a 4 ans
Référence : NCT01613586

Femme Homme

Extrait

In this study several dose levels of ASP3652, given orally for 12 weeks, will be compared with placebo in the treatment of female patients with Bladder Pain Syndrome / Interstitial Cystitis.


Critère d'inclusion

  • Cystitis, Interstitial ,Urologic Diseases ,Urinary Bladder Disease ,pain


Liens